Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma. Hoof I, Bonnelykke K, Stranzl T, Brand S, et al. Thorax 2023 Dec 30:thorax-2023-220707. doi: 10.1136/thorax-2023-220707.

Read + Share

Amedeo Smart

Independent Medical Education

Hoof I, Bonnelykke K, Stranzl T, Brand S, et al. Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma. Thorax 2023 Dec 30:thorax-2023-220707. doi: 10.1136/thorax-2023-220707.
PMID: 38160049